| Outgoing Relation(s) |
| EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor (CHEBI:60186) is a EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor (CHEBI:76895) |
| Incoming Relation(s) |
| bupivacaine (CHEBI:3215) has role EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor (CHEBI:60186) |
| bupivacaine hydrochloride (anhydrous) (CHEBI:31322) has role EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor (CHEBI:60186) |
| bupivacaine hydrochloride hydrate (CHEBI:60789) has role EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor (CHEBI:60186) |
| levobupivacaine (CHEBI:6149) has role EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor (CHEBI:60186) |
| levobupivacaine hydrochloride (anhydrous) (CHEBI:31772) has role EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor (CHEBI:60186) |
| levobupivacaine hydrochloride hydrate (CHEBI:77453) has role EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor (CHEBI:60186) |
| paxilline (CHEBI:34907) has role EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor (CHEBI:60186) |
| thapsigargin (CHEBI:9516) has role EC 3.6.3.8 (Ca2+-transporting ATPase) inhibitor (CHEBI:60186) |